The estimated Net Worth of Francine Kaufman is at least $3.12 millió dollars as of 10 February 2022. Francine Kaufman owns over 163,870 units of Senseonics Inc stock worth over $481,415 and over the last 6 years he sold SENS stock worth over $919,206. In addition, he makes $1,721,840 as Chief Medical Officer és Director at Senseonics Inc.
Francine has made over 4 trades of the Senseonics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 163,870 units of SENS stock worth $403,120 on 10 February 2022.
The largest trade he's ever made was selling 163,870 units of Senseonics Inc stock on 10 February 2022 worth over $403,120. On average, Francine trades about 19,383 units every 16 days since 2019. As of 10 February 2022 he still owns at least 1,222,175 units of Senseonics Inc stock.
You can see the complete history of Francine Kaufman stock trades at the bottom of the page.
Dr. Francine Kaufman has been appointed as Chief Medical Officer, Director of the Company. She has served as the Company’s Chief Medical Officer since March 2019. Prior to joining the Company, Dr. Kaufman served as Chief Medical Officer and Vice President of Global Clinical, Regulatory and Medical Affairs at Medtronic Diabetes from 2009 to January 2019. Prior to that, she served as Director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles from 1991 to 2009. Dr. Kaufman is also a Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California. She was formerly the president of the American Diabetes Association in 2003 and chair of the National Diabetes Education Program from 2008 to 2009. Dr. Kaufman was also elected to the National Academy of Medicine in 2005. She was also an advisor to the Governor on the California Initiative on Health, Fitness and Obesity in 2007. Dr. Kaufman received her B.A. from Northwestern University and her M.D. from Chicago Medical School.
As the Chief Medical Officer és Director of Senseonics Inc, the total compensation of Francine Kaufman at Senseonics Inc is $1,721,840. There are 1 executives at Senseonics Inc getting paid more, with Timothy Goodnow having the highest compensation of $2,211,200.
Francine Kaufman is 69, he's been the Chief Medical Officer és Director of Senseonics Inc since 2019. There are 1 older and 15 younger executives at Senseonics Inc. The oldest executive at Senseonics Holdings Inc is Dr. Francine Ratner Kaufman M.D., 70, who is the Chief Medical Officer & Director.
Francine's mailing address filed with the SEC is 20451 SENECA MEADOWS PARKWAY, , GERMANTOWN, MD, 20876.
Over the last 9 years, insiders at Senseonics Inc have traded over $36,720,504 worth of Senseonics Inc stock and bought 30,963,337 units worth $56,759,340 . The most active insiders traders include Peter J Barris, M James Barrett és Douglas A Roeder. On average, Senseonics Inc executives and independent directors trade stock every 45 days with the average trade being worth of $313,683. The most recent stock trade was executed by Sharon Larkin on 7 September 2023, trading 30,889 units of SENS stock currently worth $18,842.
senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm") system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
Senseonics Inc executives and other stock owners filed with the SEC include: